The 60 references in paper M. Sycheva G., T. Grushina I., М. Сычева Г., Т. Грушина И. (2014) “Медикаментозные средства предотвращения и минимизации лучевых повреждений легких // Drug therapy to prevent and diminish radiation injury of the lungs” / spz:neicon:pulmonology:y:2013:i:6:p:85-91

1
Ghafoori P., Marks L.B., Vujaskovic Z., Kelsey C.R. Radiation-induced lung injury. Assessment, management and prevention. Oncology 2008; 22 (1): 37–47.
(check this in PDF content)
2
Graves P.R., Siddiqui F., Anscher M.S., Movsas B.Radiation pulmonary toxicity: from mechanisms to management. Semin. Radiat. Oncol. 2010; 20 (3): 201–217.
(check this in PDF content)
3
Westbury C.B., Yarnold J.R. Radiation fibrosis – current clinical and therapeutic perspectives. Clin. Oncol. (Roy. Coll. Radiol.) 2012; 24 (10): 657–672.
(check this in PDF content)
4
Medhora M., Gao F., Jacobs E. R., Moulder J. E. Radiation damage to the lung: Mitigation by angiotensin-converting enzyme (ACE) inhibitors. Respirology 2012; 17 (1): 66–71.
(check this in PDF content)
5
Citrin D., Cotrim A.P., Hyodo F. et al. Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist 2010; 15: 360–371.
(check this in PDF content)
6
Patel V.N., Gupta S., Shareef M.M., Ahmed M.M.Contemporary radiation countermeasures. Defence Sci. J. 2011; 61 (2): 138–145.
(check this in PDF content)
7
Movsas B., Vikram B., Hauer7Jensen M. et al.Decreasing the adverse effects of cancer therapy: National Cancer Institute Guidance for the Clinical Development of Radiation Injury Mitigators. Clin. Cancer Res. 2011; 17 (2): 222–228.
(check this in PDF content)
8
Васин М.В. Классификация противолучевых средств как отражение современного состояния и перспективы развития радиационной фармакологии. Радиационная биология. Радиоэкология 2013; 53 (5): 459–467.
(check this in PDF content)
9
Стюарт Ф.А., Аклеев А.В., Хауэр7Дженсен М. и др. Отчет МКРЗ по тканевым реакциям, ранним и отдаленным эффектам в нормальных тканях и органах – пороговые дозы для тканевых реакций в контексте радиационной защиты (Труды МКРЗ; публикация 118): Пер. с англ. Под ред. А.В.Аклеева, М.Ф.Киселева. Челябинск: Книга 2012.
(check this in PDF content)
10
Antonadou D., Coliarakis N., Synodinou M. et al. Randomized phase III trial of radiation treatment / amifostine in patients with advanced-stage lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2001; 51: 915–922.
(check this in PDF content)
11
Antonadou D., Petridis A., Synodinou M. et al. Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer. Semin. Oncol. 2003; 30 (6, Suppl. 18): 2–9.
(check this in PDF content)
12
CTEP Common Toxicity Criteria, Version 2.0 DCTD, NCI, NIH, DHHS, March 1998: 24; app IV: 32.
(check this in PDF content)
13
Komaki R., Lee J.S., Kaplan B. et al. Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II–III non-small cell lung cancer: Preliminary results. Semin. Radiat. Oncol. 2002; 12 (Suppl. 1): 46–49.
(check this in PDF content)
14
Marks L.B., Yu X., Vujaskovic Z. Radiation-induced lung injury. Semin. Radiat. Oncol. 2003; 13: 333–345.
(check this in PDF content)
15
Tsoutsou P.G., Koukourarakis M.I. Radiation pneumonitis and fibrosis: mechanism underlying its pathogenesis and implications for future researche. Int. J. Radiat. Oncol. Biol. Phys. 2006; 66 (5): 1281–1293.
(check this in PDF content)
16
Movsas B., Scott C., Langer C. et al. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation Therapy Oncology Group trial 98–01. J. Clin. Oncol. 2005; 23: 2145–2154.
(check this in PDF content)
17
Ozturk B., Egehan I., Atavci S., Kitapci M.Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: a double-blind randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 2004; 58: 213–219.
(check this in PDF content)
18
Delanian S., Porcher R., Balla7Mekias S., Lefaix J.7L. Randomized, placebo-controlled trial of combined pentoxifillin and tocopherol for regression of superficial radiationinduced fibrosis. J. Clin. Oncol. 2003; 21 (13): 2545–2550.
(check this in PDF content)
19
Jacobson G., Bhatia S., Smith B.J., Button A.M. Randomized trial of Pentoxifylline and Vitamin E vs standard follow-up after breast irradiation to prevent breast fibrosis, evaluated by tissue compliance meter. Int. J. Radiat. Oncol. Biol. Phys. 2013; 85 (3): 604–608.
(check this in PDF content)
20
Moulder J.E., Cohen E.P.Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury. Semin. Radiat. Oncol. 2007; 17: 141–148.
(check this in PDF content)
21
Molteni A., Moulder J.E., Cohen E.F. et al. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II Сычева М.Г., Грушина Т.И. Медикаментозные средства предотвращения и минимизации лучевых повреждений легких type 1 receptor blocker. Int. J. Radiat. Biol. 2000; 76 (4): 523–532
(check this in PDF content)
22
Molteni A., Wolfe L.F., Ward W.F. et al. Effect of an angiotensin II receptor blocker and two angiotensin converting enzyme inhibitors on transforming growth factor-beta (TGF-β) and alpha-actomyosin (alpha SMA), important mediators of radiation-induced pneumopathy and lung fibrosis. Curr. Pharm. Des. 2007; 13: 1307–1316.
(check this in PDF content)
23
Ghosh S.N., Zhang R., Fish B.L. et al.Renin-Angiotensin system suppression mitigates experimental radiation pneumonitis. Int. J. Radiat. Oncol. Biol. Phys. 2009; 75 (5): 1528–1536.
(check this in PDF content)
24
Medhora M., Gao F., Fish B.L. et al. Dose-modifying factor for captopril for mitigation of radiation injury to normal lung. J. Radiat. Res. 2012; 53 (4): 633–640.
(check this in PDF content)
25
Molthen R.C., Wu Q., Fish B.L. et al. Mitigation of radiation induced pulmonary vascular injury by delayed treatment with captopril. Respirology 2012; 17 (8): 1261–1268. doi: 10.1111/j.1440-1843.2012.02247.x.
(check this in PDF content)
26
Williams J.P., Jackson I.L., Shah J.R. et al.Animal models and medical countermeasures development for radiationinduced lung damage: Report from an NIAID Workshop. Radiat. Res. 2012; 177: e0025–e0039. doi: 10.1667/RROL04.1
(check this in PDF content)
27
Kharofa J., Cohen E.P., Tomic R. et al. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 2012; 84 (1): 238–243.
(check this in PDF content)
28
Williams J.P, Johnston C.J., Finkelstein J.N. Treatment for radiation-induced pulmonary late effects: Spoiled for choice or looking in the wrong direction? Curr. Drug Targets 2010; 11 (11): 1386–1394.
(check this in PDF content)
29
Sun X.F., Wang L.L., Wang J.K. et al.Effects of simvastatin on lung injury induced by ischaemia-reperfusion of the hind limbs in rats. J. Int. Med Res. 2007; 35: 523–533.
(check this in PDF content)
30
Yao H.W., Mao L.G., Zhu J.P.Protective effects of pravastatin in murine lipopolysaccharide-induced acute lung injury. Clin. Exp. Pharmacol. Physiol. 2006; 33: 793–797.
(check this in PDF content)
31
Xia D.H., Xi L., Xy C. et al.The protective effects of ambroxol on radiation lung injury and influence on production of transforming growth factor beta1 and tumor necrosis factor alpha. Med. Oncol. 2010; 27 (3): 697–701. doi:10.1007/ s12032-009-9271-3.
(check this in PDF content)
32
Demedts M., Behr J., Buhl R. et al. High-dose Acetylcysteine in idiopathic pulmonary fibrosis. N. Engl. J. Med. 2005; 353: 2229–2242.
(check this in PDF content)
33
Noble P.W., Albera C., Bradford W.Z. et al.Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 2011; 377 (9779): 1760–1769.
(check this in PDF content)
34
Bargagli E., Galeazzi M., Bellisai F. et al. Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension. Respir. Intern. Rev. Thorac. Dis. 2008; 75 (3): 346–349.
(check this in PDF content)
35
Staroslawska E., Czarnocki K. J., Koziol7Montewka M. et al. Effect of infliximab on the levels of TNF-αand TGF-βin the whole blood cultures of irradiated patients. Folia Histochem. Cytobiol. 2008; 46 (3): 291–297.
(check this in PDF content)
36
Hunter N.R., Valdecanas D., Liao Z. et al.Mitigation and treatment of radiation-induced thoracic injury with a cyclooxygenase-2 inhibitor, celecoxib. Int. J. Radiat. Oncol. Biol. Phys. 2013; 85 (2): 472–476. doi: 10.1016/j.ijrobp.2012. 04.025.
(check this in PDF content)
37
Komaki R., Wei X., Allen P.K. et al. Phase I study of Celecoxib with concurrent Irinotecan, Cisplatin, and radiation therapy for patients with unresectable locally advanced nonsmall cell lung cancer. Front. Oncol. 2011; 1: 52. Published online 2011 December 13.
(check this in PDF content)
38
Epperly M., Bray J., Kraeger S. et al. Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy. Gene Ther. 1998; 5: 196–208.
(check this in PDF content)
39
Lefaix J.7L., Delanian S., Leplat J.J. et al. Successful treatment of radiation-induced fibrosis using Cu/Zn-SOD and Mn-SOD: An experimental study. Int. J. Radiat. Oncol. Biol. Phys. 1996; 35: 305–312.
(check this in PDF content)
40
Kang S.K., Rabbani Z.N., Folz R.J. et al. Overexpression of extracellular superoxide dismutase protects mice from radiation-induced lung injury. Int. J. Radiat. Biol. Oncol. Phys. 2003; 47: 1056–1066.
(check this in PDF content)
41
Rabbani Z.N., Anscher M.S., Folz R.J. et al. Overexpression of extracellular superoxide dismutase reduces acute radiation induced lung toxicity. BMC Cancer 2005; 5: 59. doi:10.1186/1471-2407-5-59.
(check this in PDF content)
42
Vujaskovic Z., Batinic7Haberle I., Rabbani Z.N. et al. A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury. Free Radic. Biol. Med. 2002; 33: 857–863.
(check this in PDF content)
43
Mahmood J., Jelveh S., Calveley V. et al. Mitigation of radiation-induced lung injury by genistein and EUK-207. Int. J. Radiat. Biol. 2011; 87 (8): 889–901.
(check this in PDF content)
44
Mahmood J., Jelveh S., Zaidi A. et al. Mitigation of radiation-induced lung injury with EUK-207 and genistein: effects in adolescent rats. Radiat. Res. 2013; 179 (2): 125–134.
(check this in PDF content)
45
Kunwar A., Jain V.K., Priyadarsini K.I., Haston C.K.A Selenocysteine Derivative therapy affects radiation-induced pneumonitis in the mouse. Am. J. Respir. Cell. Mol. Biol. 2013; 49 (4): 654–661.
(check this in PDF content)
46
Драчев И.С., Легеза В.И., Турлаков Ю.С. Перспективы применения соединений селена в качестве радиопротекторов. Радиац. биол. радиоэкол. 2013; 53 (5): 475–480.
(check this in PDF content)
47
Yazici G., Yildis F., Iskit A. et al. The effect of vitamin D prophylaxis on radiation induced pulmonary damage. J. Radiat. Res. 2011; 52 (5): 616–621.
(check this in PDF content)
48
Lee J.C, Kinniry P.A., Arguiri E. et al.Dietary curcumin increases antioxidant defenses in lung, ameliorates radiation-induced pulmonary fibrosis, and improves survival in mice. Radiat. Res. 2010; 173 (5): 590–601.
(check this in PDF content)
49
Cho Y.J., Yi Ch.O., Jeon B.T. et al. Curcumin attenuates radiation-induced inflammation and fibrosis in rat lungs. Korean J. Physiol. Pharmacol. 2013; 17 (4): 267–274. English. Published online 2013 July 30.
(check this in PDF content)
50
Liu Y., Yu H., Zhang C.Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer. Eur. J. Cancer 2008; 44: 2425–2432.
(check this in PDF content)
51
Calveley V.L., Jelveh S., Langan A. et al.Genistein can mitigate the effect of radiation on rat lung tissue. Radiat. Res. 2010; 173 (5): 602–611.
(check this in PDF content)
52
Xavier S., Piek E., Fujii M. et al. Amelioration of radiationinduced fibrosis: inhibition of transforming growth factorbeta signalling by halofuginone. J. Biol. Chem. 2004; 279 (15): 15167–15176.
(check this in PDF content)
53
Liu H., Xue J.X., Li X. et al.Quercetin liposomes protect against radiation-induced pulmonary injury in a murine model. Oncol. Lett. 2013; 6 (2): 453–459.
(check this in PDF content)
54
Robb W.B., Condron C., Moriarty M. et al.Taurine attenuates radiation-induced lung fibrosis in C57/Bl6 fibrosis prone mice. Irish J. Med. Sci. 2010; 179 (1): 99–105.
(check this in PDF content)
55
Brizel D.M.Pharmacologic approaches to radiation protection. J. Clin. Oncol. 2007; 25 (26): 4084–4089.
(check this in PDF content)
56
Haiping Z., Takayama K., Uchino J. et al.Prevention of radiation-induced pneumonitis by recombinant adenovirusmediated transferring of soluble TGF-beta type II receptor gene. Cancer Gene Ther. 2006; 13 (9): 864–872.
(check this in PDF content)
57
Katoh H., Ishikawa H., Hasegava M. et al. Protective effect of urinary trypsin inhibitor on the development of radiationinduced lung fibrosis in mice. J. Radiat. Res. 2010; 51 (3): 325–332.
(check this in PDF content)
58
Shimbo T., Inomata T., Takahashi M.et al. Effects of sivelestat sodium hydrate on the reduction of radiation pneumonitis. Int. J. Mol. Med. 2007; 20 (6): 817–822.
(check this in PDF content)
59
Fox J., Haston C.K. CXC receptor 1 and 2 and neutrophil elastase inhibitors alter radiation-induced lung disease in the mouse. Int. J. Radiat. Oncol. Biol. Phys. 2013; 85 (1): 215–222. doi: 10.1016/j.ijrobp.2012.02.024.
(check this in PDF content)
60
Li M., Abdollahi A., Grone H.L. et al.Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model. Radiat. Oncol. 2009; 4: 66. Published online 2009 December 21. Информация об авторах
(check this in PDF content)